A synergy between mechanosensitive calcium- and membrane-binding mediates tension-sensing by C2-like domains
When nuclear membranes are stretched, the peripheral membrane enzyme cytosolic phospholipase A2 (cPLA ) binds via its calcium-dependent C2 domain (cPLA -C2) and initiates bioactive lipid signaling and tissue inflammation. More than 150 C2-like domains are encoded in vertebrate genomes. How many of t...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 119; no. 1 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
04.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | When nuclear membranes are stretched, the peripheral membrane enzyme cytosolic phospholipase A2 (cPLA
) binds via its calcium-dependent C2 domain (cPLA
-C2) and initiates bioactive lipid signaling and tissue inflammation. More than 150 C2-like domains are encoded in vertebrate genomes. How many of them are mechanosensors and quantitative relationships between tension and membrane recruitment remain unexplored, leaving a knowledge gap in the mechanotransduction field. In this study, we imaged the mechanosensitive adsorption of cPLA
and its C2 domain to nuclear membranes and artificial lipid bilayers, comparing it to related C2-like motifs. Stretch increased the Ca
sensitivity of all tested domains, promoting half-maximal binding of cPLA
at cytoplasmic resting-Ca
concentrations. cPLA
-C2 bound up to 50 times tighter to stretched than to unstretched membranes. Our data suggest that a synergy of mechanosensitive Ca
interactions and deep, hydrophobic membrane insertion enables cPLA
-C2 to detect stretched membranes with antibody-like affinity, providing a quantitative basis for understanding mechanotransduction by C2-like domains. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by James Hurley, Department of Molecular and Cell Biology, California Institute for Quantitative Biosciences, University of California, Berkeley, CA; received July 5, 2021; accepted November 19, 2021 Author contributions: Z.S. and P.N. designed the research; Z.S. and K.T.B. performed the research; Z.S., M.J., K.L.H., A.K., and P.N. contributed new reagents/analytic tools; Z.S. and P.N. analyzed the data; and Z.S. and P.N. wrote the paper. 2Present address: University Program in Genetics and Genomics, Duke University School of Medicine, Durham, NC 27705. 1Present address: Fate Therapeutics, Inc., San Diego, CA 92121. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.2112390119 |